
To qualify for participation in this study, individuals must meet the following minimum criteria:
- Diagnosis of type 1 diabetes (according to ADA criteria) within the past 6 weeks.
- Male or female 8–30 years old
- Body weight of at least 25 kg
- Insulin autoantibodies, assessed within 10 days of any insulin use; anti- GAD autoantibodies; or anti-ICA512/IA-2 autoantibodies.
Individuals meeting any of the criteria below will not be eligible to participate in the study. Additional exclusion criteria may apply.
- Asthma
- Prior participation in a clinical trial that could potentially affect diabetes or immunologic status
- Participation in an investigational clinical trial within the last 6 weeks before enrollment
- Pregnancy or breastfeeding
|
|
|
AbATE Trial Menu
Overview
A description of the rationale, design treatments used for the study
>> <<
Inclusion and exclusion criteria for the study. Locations & Contacts
Where the study is being conducted, with contact information.
|
|